Molecular mechanism of GANT61 combined with doxorubicin in the treatment of gliomas based on network pharmacology
Tài liệu tham khảo
Sun, 2019, RRM2 is a potential prognostic biomarker with functional significance in glioma, Int J Biol Sci, 15, 533, 10.7150/ijbs.30114
Huang J, Chen H, Wei Q, et al. Downregulation of LKB1 promotes tumor progression and predicts unfavorable prognosis in patients with glioma. Oncol Lett, 2017;13(3):1688–1694. https://doi.org/10.3892/ol.2017.5631. PMid: 28454310.
Liu, 2016, Dual receptor recognizing cell penetrating peptide for selective targeting, efficient intratumoral diffusion and synthesized anti-glioma therapy, Theranostics, 6, 177, 10.7150/thno.13532
Joshi, 2016, Liposome size and charge optimization for intraarterial delivery to gliomas, Drug Deliv Translat Res, 6, 225, 10.1007/s13346-016-0294-y
Zong, 2014, Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals, Mol Pharm, 11, 2346, 10.1021/mp500057n
Wang, 2011, Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial, Radiother Oncol, 100, 200, 10.1016/j.radonc.2011.07.007
Kiyokawa, 2019, Preclinical and clinical development of oncolytic adenovirus for the treatment of malignant glioma, Oncolytic virotherapy, 8, 27, 10.2147/OV.S196403
Zhang, 2021, Application progress of network pharmacology in traditional chinese medicine research, J Nanjing Univ Tradit Chinese Med, 37, 156
Gong, 2021, Anti-aging function and molecular mechanism of Radix Astragali and Radix Astragali preparata via network pharmacology and PI3K/Akt signaling pathway, Phytomedicine, 84, 153509, 10.1016/j.phymed.2021.153509
Yuan, 2021, Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer, Life Sci, 270, 119105, 10.1016/j.lfs.2021.119105
Chaturvedi NK, Kling MJ, Coulter DW, et al. Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy. Oncotarget, 2018;9(24):16619–16633. https://doi.org/10.18632/oncotarget.24618, PMid: 29682173.
Koike, 2017, Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells, Breast Cancer, 24, 683, 10.1007/s12282-017-0757-0
Geng L, Lu K, Li P, et al. GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3. Oncotarget, 2017;8(30):48701–10. https://doi.org/10.18632/oncotarget.9792, PMid: 27275540.
Li, 2018, Effect of GANT61 on the proliferation, migration, and invasion ability of Hela cells, Med J Wuhan Univ, 39, 394
Borah, 2020, GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma, Nanotechnology, 31, 185102, 10.1088/1361-6528/ab6d20
Cohen, 2004, United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets, Clin Cancer Res, 10, 1212, 10.1158/1078-0432.CCR-03-0564
Massagué, 2016, Metastatic colonization by circulating tumour cells, Nature, 529, 298, 10.1038/nature17038
Chen, 2017, Cadherin switching induced by P120-catenin can promote the migration and invasion of oral squamous cell cancer cells, West China J Stomatol, 35, 183
Kalluri, 2009, The basics of epithelial-mesenchymal transition, J Clin Investig, 119, 1420, 10.1172/JCI39104
Kagaya, 2002, Abscisic acid-induced transcription is mediated by phosphorylation of an abscisic acid response element binding factor, TRAB1, Plant Cell, 14, 3177, 10.1105/tpc.005272
Ashburner, 2000, Gene ontology: tool for the unification of biology, Nat Genet, 25, 25, 10.1038/75556
Meek, 2015, Regulation of the p53 response and its relationship to cancer, Biochem J, 469, 325, 10.1042/BJ20150517
Gao S, Li D. Research advances in tumor necrosis factor and cancer. Chinese Pharmacological Bulletin, 2020;36(09):1209-1213. [Accessed: 23 March, 2021]. Available from: http://kns.cnki.net/kcms/detail/detail.aspx?FileName=YAOL202009006&DbName=CJFQ2020.
Armas-López L, Zúñiga J, Arrieta O, et al. The Hedgehog-GLI pathway in embryonic development and cancer: implications for pulmonary oncology therapy. Oncotarget, 2017;8(36):60684–703. https://doi.org/10.18632/oncotarget.19527 PMid: 28948003.
Han YD, Sun YX, Zhang YS, et al. High DPP4 expression predicts poor prognosis in patients with low-grade glioma. Mol Biol Rep, 2020;47(3):2189-2196. https://doi.org/10.1007/s11033-020-05321-w PMid: 32076999.
He Y, Zhong W, Li Y. Progress in the diagnosis and treatment of recurrent gliomas. Hainan Med J, 2021;32(02):246-249. [Accessed: 21 March, 2021]. Available from: http://kns.cnki.net/kcms/detail/detail.aspx?FileName=HAIN202102029&DbName=CJFQ2021.
Lee, 2014, Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth, Obstetrics Gynecol Sci, 57, 526, 10.5468/ogs.2014.57.6.526
Xue Q, Cao L, Chen X-Y, et al. High expression of MMP9 in glioma affects cell proliferation and is associated with patient survival rates. Oncol Lett, 2017;13(3):1325–1330. https://doi.org/10.3892/ol.2017.5567 PMid: 28454256.
Zhang M, Li Y, Zhang Y. Expression and significance of MMP3, TIMP-1 and VEGF in glioma. Modern Med J China, 2014;16(02):20-22. [Accessed: 11 December, 2020].Available at: http://kns.cnki.net/kcms/detail/detail.aspx?FileName=ZHTY201402009&DbName=CJFQ2014.
Oh, 2017, Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma, PLoS ONE, 12, e0178881, 10.1371/journal.pone.0178881
Sokolowska, 2008, Effects of PACAP and VIP on cAMP-generating system and proliferation of C6 glioma cells, J Mol Neurosci, 36, 286, 10.1007/s12031-008-9071-9
Nakagawa, 2002, Increased expression and secretion of r-Gsp protein, rat counterpart of complement C1s precursor, during cyclic AMP-induced differentiation in rat C6 glioma cells, Mol Brain Res, 106, 12, 10.1016/S0169-328X(02)00404-7
Van Kolen, 2004, P2Y12 receptor stimulation inhibits β-adrenergic receptor-induced differentiation by reversing the cyclic AMP-dependent inhibition of protein kinase B, J Neurochem, 89, 442, 10.1111/j.1471-4159.2004.02339.x
Walia MK, Ho PMW, Taylor S, et al. Activation of PTHrP-cAMP-CREB1signaling following p53 loss is essential for osteosarcoma initiation and maintenance. E life, 2016;5:e13446. https://doi.org/10.7554/eLife.13446 PMid: 27070462.
Peverelli, 2017, Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells, Cancer Lett, 406, 54, 10.1016/j.canlet.2017.07.025